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Background: Transcatheter Ventricular septal defect (VSD) device
closure is an accepted treatment option for isolated muscular
VSDs & certain membranous VSDs.
Methods: VSD transcatheter closure was attempted in 120 pa-
tients with various devices indifferent anatomical types of VSD
between November 2008 & July 2014 using antegrade approach in
all cases except one.
Results: Twenty seven perimembranous, 64 basal-muscular, 20
mid-muscular, 6 sub-pulmonic VSDs were successfully closed. 3
patients had multiple VSDs. Median VSD size was 5 mm. Average
fluoro-time was 24min (range 12e42minutes) which decreased to
11-15min in 2013-14 with increasing operator experience. Devices
implantedwere duct occluder in 100, muscular device in 13, septal
occluder in 1, asymmetric (2 cases)& symmetric perimembranous
devices (1 case). The procedure was successful in 106 cases (91%)
with complete closure of the shunt immediate post-procedure or
within 24 hours, without any complications. Repeat echo was
done at out-patient follow up at 48 hours, 6months,& then yearly.
Surgical intervention was sought in 7 cases during the initial
learning curve (2-device embolization, 2-tricuspid regurgitation,
1-complete heart block, 1-persistent hematuria,1-significant re-
sidual shunt). Four patients with post-procedure junctional
rhythm (treated with oral steroids), 3 with asymptomatic RBBB& 2
with mild aortic regurgitation (AR) are under continuous close
follow-up. In 3 patients, the procedure was abandoned due to
intra-procedural conduction defect/arrhythmias in 2 &AR in 1.
Conclusion: Complications of transcatheter closure of congenital
VSDs are limited, mostly seen during the initial learning curve.
More experience &long-term follow-up confirm the safety & effi-
cacy as a viable alternative to surgery. This study also demon-
strates the feasibility of use of duct occluder for VSD closure,
including subpulmonic VSDs.
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Background: PVBD is the treatment of choice for congenital PV
stenosis, with proven good short term results. This review was
designed to study demographic profile of, and document early and
late outcomes after percutaneous balloon dilation (PVBD) in pa-
tients presenting to a tertiary care centre with pulmonic stenosis.
Material and Methods: Demographic, clinical and echocardio-
graphic data regarding PVBD was reviewed for patients undergo-
ing PVBD between 2001 and 2014.The dilation was done from
femoral venous access by previously described standard methods
after crossing the stenosed valve. Semicompliant Tyshak balloons
if annulus < 22 mm and Accura balloons if PV annulus > 22 mm
were used to dilate the valve with maximum BAR (Balloon-to-
annulus ratio) of 140%. PVBD procedures were done from jugular
access in 3 cases due to severe TR in RV dysfunction precluding
wire and catheter entry from RA to RV despite multiple attempts.
Successful PVBDwas defined as reduction of RV-toePA gradient >
50% with no complications.
Results: In the study period mentioned above, 1041 (M¼529:
F¼512) patients underwent PVBD of whom 82 patients underwent
the procedure twice (of these 82, 8 were Noonan phenotype). 126
patients had at least additional mild infundibular PS, 379 had a
concomitant ostium secundum ASD and 12 had tiny basal
muscular (n¼7) and 5 had small apical muscular VSD. 19 patients
were congenital rubella syndrome phenotype, and Noonan syn-
drome phenotype was seen in 32 patients, though genetic testing
was not available. The youngest patient was a 7-day oldmale child
and the oldest was 60 year old (mean age13, median age¼10.5 yrs).
PV gradients decreased from mean 78+/-30 mmHg to 24+/-19 mm
Hg (p<0.0001) and remained low during amean follow-up of 8.9+/-
3.1 (range 3.7 to 14 years).
PVBD was also done for TOF patients (n¼15), for Dysplastic
valves (n¼22), Supravalvular PS in 19 cases with PVBD and RPA
plasty done in 3 cases and Ebstein’s anomaly with valvular PS in
one case. RVOT conduit dilation for stenosed Hemashield graft
was also done in one case with post-truncal repair conduit ste-
nosis. PVBD was done for 82 patients of PS with severe RV
dysfunction and 92% patients in this group had satisfactory im-
mediate and dramatic results with RV function starting to
improve as early as 24 hours post PVBD. Concomitant ASD device
closure with PVBD was done in 11 patients.
Freedom from re-intervention at 1, 10 and 14 years were: 99%,
96%, and 91% respectively among the patients who continued to
be followed up. Moderate post-PVBD pulmonary regurgitation (PR)
occurred in upto 49% patients after PVBD but decreased during
follow-up. The gradient across the stenosed valve in successful
PVBD showed an immediate post-PVBD fall, followed by a trend to
decrease further over time due to favourable RV remodeling and
regression of RV hypertrophy. Predictors of less favourable PVBD
result requiring repeat PVBD were initial high RV-to-PA gradients
> 75 mm Hg, PVBD for dysplastic valves, PVBD in Noonan syn-
drome, presence of additional severe infundibular stenosis,
presence of hypoplastic annulus, and severe RVH.
Conclusions: Starting even from neonatal PS, PVBD is an effica-
cious procedure for treatment of congenital pulmonic stenosis
with satisfactory short and long term results in patients, and is
associated with immediate fall in PV gradients and dramatic
improvement of RV function,though RVH regression occurs in
majority of patients over a longer time period. Although post-
PVBD PR occurs commonly, it is well tolerated and decreases
eventually over time. Even in patients with an initial favourable
result, gradients continue to declinewith continued favourable RV
remodeling indicating that immediate post-PVBD gradient alone
may not be the only predictor of longer term favourable outcomes.
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Background: As the Tetralogy of Fallot (TOF) is the most common
cyanotic heart disease, and the anatomy of pulmonary artery is
the key determinant for surgical repair, precise assessment of
pulmonary artery by some readily available harmless simple
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technique is must; and in that scenario echocardiography has an
edge over other modalities. Moreover studies showed a good
correlation of echocardiographic measurements with angio-
graphic ones which is being supposed to be mandatory by sur-
geons. The aim of this work was to evaluate the reliability and
strength of non-invasive assessment of the pulmonary anatomy
by comparative study.
Method: 76 patients (mean age 38± 27 mo) with only usual anat-
omy of TOF were included and echocardiography assessment was
done for all. Alternate child was undergone either (multi-detector
cardiac CT 64 slice(MDCT-group 1) or cardiac cath-angio (CCA-
group 2) before total surgical repair (done in 24 patient till date)
and parameters measured by each modality was compared. Pa-
rameters are ‘Pulmonary artery index (PAI) according to Nakata’
and ‘McGoon’, ‘Z-value for the pulmonary artery branches’ and
‘pulmonary annulus Z score’ (age adjusted ‘z’ score calculated
using Detroit data).
Result: The results showed that in group 1, though there was some
difference in measurement of RPA & LPA in pre-branching
segment measured by echo and MDCT, a statistically significant
correlation (r value 0.68, p value 0.0005) in the measurements of
RPA & LPA and consequently the calculated Z value and the PAI
between the two modalities was found; and similarly, group II
patients demonstrated a statistically significant correlation (r
value 0.56, p value 0.008) of measurements of RPA & LPA and
consequently the calculated Z value and the PAI between the
echocardiographic and CCA methods. The correlation between
the echocardiographic and the MDCT measurements was stron-
ger than those detected between the echocardiographic and
angiographic measurements. And moreover in group 1 non-
invasively obtained parameter correlated better with surgically
found measurement than those obtained by CCA in group 2. The
maximum difference between the echocardiography and surgery
for the RPA & LPA was 2.4 mm and 2.0 mm and the mean differ-
ence was 0.81 ± 0.43 and 0.64 ± 0.48 mm respectively. Detection of
associated cardiac anomalies, MAPCAs, coronary anomaly was
not greater by CCA than MDCT also.
Conclusion: A 2-D echocardiography is accurate and precise in
estimation of the pulmonary artery branches and thus surgical
management of usual TOF, can be supplemented by non-invasive
MDCT in selected cases for information aboutMAPCAs, associated
anomalies, patient with poor echo-window etc. Invasive cardiac
catheterization can easily be avoided along with its usual hazards
like radiation and nephrotoxicity.
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Background: Hemoptysis is a common cause of morbidity in
Eisenmenger syndrome, but the causes of hemoptysis are not well
defined. We analyzed the clinical predictors and causes of he-
moptysis in a cohort of patients with Eisenmenger syndrome
using computerized tomographic pulmonary angiography (CTPA).
Methods: Of the 95 patients of Eisenmenger syndrome studied
(mean age 23.7 ± 7.7 years; 57 male), 38 patients (40%) had pre-
sented with hemoptysis, and all of them underwent a CTPA
within two weeks of index bleed.
Results: Patients with hemoptysis had a reduced 6 minute walk
distance (356.2 ± 92.5 meters) as compared to patients without
hemoptysis (395.1 ± 126.9 meters) (p ¼ 0.03). However, other
baseline demographic characteristics including diagnosis,
complexity of lesion, functional class, and symptoms did not
differ among patients with and without hempotysis. Of the 38
patients, 17 had a treatable cause of hemoptysis and received
appropriate treatment. The identifiable causes included aorto-
pulomanray collaterals, pulmonary thrombosis (2 patients), pul-
monary tuberculosis (2 patients), pulmonary artery dissection (1
patient). Treating an identifiable cause reduced the risk of recur-
rence of hemoptysis by 0.46 (95% CI 0.28 e 0.64).
Conclusion: Hemoptysis remains a major cause of morbidity in
patients with Eisenmenger syndrome. Hemoptysis occurs more
frequently in patients with greater exercise limitation. CT pul-
monary angiogram immediately following an episode of hemop-
tysis could identify a potentially treatable cause in nearly half of
the patients and such treatment results in lesser recurrence of
hemoptysis.
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Introduction: Ventricular septal defects are the most common
congenital cardiac defects (30% of all CHD). Perimembranous de-
fects account for 70% of these cases, while muscular defects ac-
count for 20%. Surgery is the standard therapy with low mortality
and complications rate. It requires cardiopulmonary bypass with
significant inflammatory response, surgical scar, limitations of
activity following surgery. Transcatheter closure of VSDs has been
introduced, advanced rapidly, with improvements in device de-
signs. Aim of the work is to report the early results of trans-
catheter VSD closure in cardiology Unit, Children Hospital,
Mansoura University.
Methods: 26 patients have undergone transcatheter closure of
VSD, 15 were males and 11 were females, age ranges from4 to 23
years. Patients should have significant left to right shunt through
VSD (Frequent chest infections, Effort intolerance, Cardiomegaly due to
LA, LV dilatations and increased LV EDD > 2 SD).Anatomy suitable for
transcatheter closure: rim of¼/> 5mm separating VSD from aortic
valve, tricuspid valve.
All the patients were generally anesthetized using cevoflurane,
20proceduresweredoneunder TEE, onewithTTE andfluoroscopic
guidance, Right and left heart catheterizationwere done according
to standard protocols, Patients received 100 IU/Kg Heparin and
100mg/Kg Cephalosporin, Shunts and PVR were calculated.
Results: 13 cases had perimembranous VSD, one of them was
associated with PDA, 4 cases with muscular outlet VSD, 5 cases
with mid muscular VSD, 4 cases were residual following VSD
surgical closure. For perimembranous VSD 7 ADO I , 6 PFM Nit
occlude coil were used, for muscular outlet VSD 1 Amplatzer
MVSD, 1 ADOI, 2 PFMNit occlude coil were used, for midmuscular
VSD 3 Amplatzer MVSD , 2 PFM Nit occlude coil, for residual s/p
surgical VSDs 1 ADO II , 3 PFM Nit Occlud coil were used. One ADO
I device embolized in perimembranous VSD which was retrieved
successfully.
Conclusion: Transcatheter closure of VSD has encouraging re-
sults. Excellent closure rates on short term follow up with Low
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